Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison. - Concepedia

Concepedia

Publication | Closed Access

Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison.

11

Citations

0

References

2007

Year

M Mansueto, Adelmo Grimaldi, Aleksandra Torbica, Gino Pepe, Giampiero Giovacchini, C. Messa, Ferruccio Fazio

Abstract

In Italy, the introduction of PET in the clinical management of all patients with known or suspected lung cancer previously evaluated with CT is cost-effective and allows to gain 2.64 life years at an annual cost of about 415 Euro.